V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20136771 | 20134307 | null | null | Curative (C) | 2018-12-13 | 2019-08-29 | TOPOTECAN | 02 | N | HEPATOBLASTOMA VHR BLOCK C CARBO (AUC6.6)/DOX | 100470005 |
| 20137001 | 20134308 | 1.56 | 106.5 | 03 | 2018-08-08 | 2018-08-18 | SCOPE 2 TRIAL | 02 | null | CARBOPLATIN + EPIRUBICIN + FLUOROURACIL | 101120480 |
| 20137438 | 20134309 | 1.53 | 62.2 | null | 2020-04-13 | 2020-05-18 | ABVD | 02 | N | NAB-PACLITAXEL | 101069527 |
| 20137502 | 20134310 | 1.69 | 85 | Palliative (P) | 2020-07-02 | 2020-10-13 | PHITT D Carboplatin/Doxorubicin | 02 | N | EOF | 101078161 |
| 20137533 | 20134311 | 1.8 | 88 | Palliative (P) | 2019-04-13 | 2019-04-13 | DARATUMUMAB | 02 | N | EC + PACLITAXEL | 101488838 |
| 20137633 | 20134312 | 1.82 | 70.1 | null | 2019-11-30 | 2019-12-09 | Gemcitabine + Oxaliplatin | 02 | N | PACLITAXEL + RAMUCIRUMAB | 101081602 |
| 20137750 | 20134313 | 1.54 | 62 | Palliative (P) | 2020-04-03 | 2020-04-25 | Bortezomib + Panobinostat | 02 | null | ECF | 100617711 |
| 20138126 | 20134316 | 1.77 | 79.2 | Palliative (P) | 2022-05-07 | 2022-05-14 | Eribulin | 02 | N | NINTEDANIB | 101600837 |
| 20138325 | 20134317 | 1.83 | 117 | Neo-adjuvant (N) | 2020-07-26 | 2020-08-24 | ECF | N | N | FOCUS4 TRIAL | 101400423 |
| 20138373 | 20134318 | 1.71 | 74.25 | Palliative (P) | 2017-03-10 | 2017-03-10 | Cetuximab + OXALIPLATIN + RALTITREXED | 02 | null | CAPE + OXALIPLATIN + TRASTUZUMAB | 101440199 |
| 20138608 | 20134319 | 1.56 | 122 | Palliative (P) | 2015-03-09 | 2017-07-09 | Rituximab | N | Y | ATEZOLIZUMAB | 100027479 |
| 20139090 | 20134320 | 1.62 | 75.4 | null | null | 2019-09-01 | Carboplatin + Pemetrexed | null | N | ATEZOLIZUMAB + NAB-PACLITAXEL | 101257179 |
| 20139601 | 20134321 | 1.8 | 74.7 | null | 2017-10-12 | 2017-10-26 | CAPECITABINE + OXALIPLATIN + RT | 2 | N | IRINOTECAN + MDG + PANITUMUMAB | 101364005 |
| 20139650 | 20134322 | 1.82 | 61.1 | null | null | 2019-04-06 | R-GDP | 99 | null | CHLORAMBUCIL + OBINUTUZUMAB | 101453516 |
| 20139686 | 20134324 | 1.8 | 45 | Palliative (P) | 2016-08-31 | 2016-09-08 | Bortezomib (weekly) | 02 | N | VINORELBINE | 100253851 |
| 20139687 | 20134325 | 1.77 | 84.8 | Palliative (P) | 2017-02-10 | 2018-02-09 | INTERAACT trial | 01 | N | IBRUTINIB | 100870804 |
| 20139700 | 20134326 | 1.57 | 65 | 03 | 2019-09-08 | 2019-12-13 | FOXTROT TRIAL | N | N | CISPLATIN + FLUOROURACIL + STREPTOZOCIN | 100217476 |
| 20139972 | 20134327 | 1.7 | 95 | Palliative (P) | 2018-03-08 | 2018-03-29 | Cabazitaxel | 02 | N | IRINOTECAN + RALTITREXED | 101249641 |
| 20140316 | 20134328 | 1.9 | 73 | null | 2019-07-22 | 2019-08-11 | Radium 223 | 02 | N | ECARBOX | 100463450 |
| 20140580 | 20134329 | 1.87 | 61.8 | null | 2019-05-15 | 2019-05-15 | CHOP R - 21 days | Y | N | DOCETAXEL + GEMCITABINE | 100031062 |
| 20140977 | 20134330 | 1.52 | 55.7 | Palliative (P) | 2017-06-07 | 2017-06-13 | Rituximab + Venetoclax | 02 | N | ECARBOX | 101042077 |
| 20141383 | 20134331 | null | null | Curative (C) | 2020-03-28 | 2020-04-04 | IBRUTINIB | 01 | N | ECARBOX | 100350891 |
| 20141452 | 20134332 | 0 | 0 | Curative (C) | 2018-03-26 | 2018-04-08 | PACLITAXEL + RAMUCIRUMAB | N | N | NB RELAPSED IRINOTECAN AND TEMOZOLOMIDE | 100507400 |
| 20141651 | 20134333 | 1.6 | 80.2 | Palliative (P) | 2017-04-27 | 2017-05-08 | IRINOTECAN + MDG + PANITUMUMAB | 02 | null | BACILLUS CALMETTE-GUERIN | 100425644 |
| 20141745 | 20134335 | 1.53 | 91.4 | Palliative (P) | 2013-10-11 | 2016-12-28 | Cisplatin +FU +Trastuzumab - Load | null | N | MIC | 101465889 |
| 20141972 | 20134338 | 1.65 | 70 | Palliative (P) | 2020-05-12 | 2020-05-12 | Cisplatin + Docetaxel +Fluorouracil | 01 | N | BEVACIZUMAB + CAPECITABINE + IRINOTECAN | 100555691 |
| 20142380 | 20134339 | 1.75 | 61.8 | Palliative (P) | null | 2020-05-30 | CAPECITABINE + OXALIPLATIN + PEMBROLIZUMAB | null | N | TEMOZOLOMIDE | 101502304 |
| 20142414 | 20134340 | 1.58 | 81.1 | Neo-adjuvant (N) | 2019-10-01 | 2019-10-06 | Docetaxel + Trastuzumab (Maint) | N | N | CAPECITABINE + IRINOTECAN + PANITUMUMAB | 100521092 |
| 20142471 | 20134341 | 1.58 | 61.9 | Palliative (P) | 2015-12-12 | 2016-06-27 | Carboplatin + Vinorelbine Oral | N | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100134933 |
| 20142578 | 20134342 | 1.69 | 70.35 | null | 2017-04-30 | 2017-05-25 | Gemcitabine + Oxaliplatin | N | N | DURVALUMAB | 100943522 |
| 20142601 | 20134343 | 1.46 | 73.2 | Palliative (P) | 2018-03-26 | 2018-03-27 | Azacitidine | 02 | null | CEDAR TRIAL | 100363501 |
| 20142633 | 20134344 | 1.83 | 82 | Disease modification (D) | 2020-06-14 | 2020-06-28 | Radium 223 | N | Y | CARBOPLATIN + FLUOROURACIL + STREPTOZOCIN | 100107551 |
| 20142915 | 20134345 | 1.71 | 46 | null | 2018-05-21 | 2018-05-31 | Topotecan (oral) | 02 | null | ALECTINIB | 100097838 |
| 20143170 | 20134346 | 1.83 | 79 | Palliative (P) | 2018-05-11 | 2018-05-11 | TEMOZOLOMIDE | N | N | PEMBROLIZUMAB + PEMETREXED | 101220913 |
| 20143228 | 20134347 | 1.75 | 54.2 | Neo-adjuvant (N) | 2016-07-11 | 2016-07-11 | CARFILZOMIB + LENALIDOMIDE | null | N | IXAZOMIB + LENALIDOMIDE | 101470244 |
| 20143244 | 20134348 | 1.69 | 44 | Palliative (P) | 2018-05-17 | 2018-05-21 | null | N | N | IPILIMUMAB + NIVOLUMAB | 100190619 |
| 20143370 | 20134349 | 1.75 | 40.4 | null | 2016-06-15 | 2016-11-05 | INTERAACT trial | N | null | ESPAC TRIAL | 100028118 |
| 20143402 | 20134350 | 1.61 | null | Adjuvant (A) | 2020-01-12 | 2020-01-19 | CARBOPLATIN + TEYSUNO | 02 | Y | CISPLATIN + FLUOROURACIL + TRASTUZUMAB | 100553504 |
| 20143492 | 20134352 | 1.57 | 73.3 | Palliative (P) | 2020-05-02 | 2020-05-09 | CAPECITABINE + OXALIPLATIN + PEMBROLIZUMAB | 02 | N | IBRUTINIB | 100834785 |
| 20143583 | 20134353 | 1.71 | 152 | null | null | 2020-06-07 | AVAPRITINIB | N | null | CAPECITABINE + IRINOTECAN + PANITUMUMAB | 100397692 |
| 20143702 | 20134354 | 1.55 | 64.7 | null | 2016-12-29 | 2017-07-03 | PACLITAXEL + TRASTUZUMAB | 99 | null | CARBOPLATIN + DOCETAXEL + TRASTUZUMAB | 100482860 |
| 20143901 | 20134356 | 1.52 | 63 | Palliative (P) | 2019-03-03 | 2019-03-11 | Cisplatin +FU +Trastuzumab - Load | N | N | CAPECITABINE + STREPTOZOCIN | 101252005 |
| 20143988 | 20134357 | 1.8 | 63 | Palliative (P) | 2019-08-08 | 2019-08-29 | Cape +Cetuximab +Oxalip (3 wk)Maint | N | null | HEPATOBLASTOMA VHR BLOCK A CISPLATIN/DOX | 101187221 |
| 20144063 | 20134358 | 1.71 | 88.7 | 03 | 2018-11-14 | 2018-12-10 | Obinutuzumab +CVP | 02 | N | GEMCITABINE + OXALIPLATIN | 100273877 |
| 20144687 | 20134359 | 1.77 | 67.8 | Palliative (P) | 2017-06-14 | 2017-06-21 | FOXFIRE TRIAL | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE | 100262936 |
| 20144809 | 20134360 | 1.65 | 80.05 | Palliative (P) | 2019-06-04 | 2019-06-05 | IRINOTECAN + MDG + PANITUMUMAB | N | N | FOCUS4 TRIAL | 100361698 |
| 20144867 | 20134361 | 1.8 | 78 | Palliative (P) | 2018-01-09 | 2018-01-30 | AXITINIB | N | N | ERIBULIN | 100413733 |
| 20145152 | 20134362 | 1.81 | 14.5 | Palliative (P) | 2017-11-24 | 2018-03-26 | Bortezomib + CYCLOPHOSPHAMIDE | N | null | MITOMYCIN | 100628854 |
| 20145263 | 20134363 | 1.62 | 67.7 | null | 2019-09-12 | 2019-09-26 | PHITT D Carboplatin/Doxorubicin | 2 | null | CARBO + FLUOROURACIL | 100179937 |
| 20145424 | 20134364 | null | 55 | Palliative (P) | 2018-10-07 | 2018-10-16 | FCarboSt | 02 | Y | PHITT | 101806526 |